Appendiceal cancer masked as inflammatory appendicitis in the elderly, not an uncommon presentation (Surveillance Epidemiology and End Results (SEER)-Medicare Analysis)

被引:12
|
作者
Siddharthan, Ragavan V. [1 ]
Byrne, Raphael M. [1 ]
Dewey, Elizabeth [1 ]
Martindale, Robert G. [1 ]
Gilbert, Erin W. [1 ]
Tsikitis, Vassiliki L. [1 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Surg, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA
关键词
appendiceal cancer; appendicitis; misdiagnosis; SEER-Medicare; INTERVAL APPENDECTOMY; INCREASED RISK; NEOPLASM; THERAPY; TUMORS; MASS;
D O I
10.1002/jso.25641
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The misdiagnosis of appendiceal cancer as inflammatory appendicitis is becoming of greater clinical concern because of the rise of nonoperative management especially in the elder population. To quantify this rate of misdiagnosis, we retrospectively reviewed SEER-Medicare data. Methods The SEER-Medicare database was reviewed from 2000 to 2014. We identified patients older than 65 years old who were diagnosed with appendiceal cancer and then cross-referenced them for a diagnosis of inflammatory appendicitis. Demographic data and oncologic stage were collected. Results Our results showed that 28.6% of appendiceal cancer patients received an incorrect initial diagnosis of inflammatory appendicitis. Patients older than 75 years of age were more likely to be misdiagnosed than those between ages 65 and 75 (risk ratio [RR]: 0.81; 95% confidence interval: 0.70-0.93; P = .003). We found that 42% of patients within the misdiagnosis group presented with an earlier stage of disease (stage 1 or 2) compared to 26% of those primarily diagnosed with appendiceal cancer (P < .001). Conclusion A significant proportion of patients older than 65 years old with appendiceal cancer were initially misdiagnosed with acute appendicitis. We suggest caution when considering a nonoperative approach for appendicitis in the elderly and follow-up imaging or an interval appendectomy should be part of the treatment plan.
引用
收藏
页码:736 / 739
页数:4
相关论文
共 50 条
  • [1] Time to Malignant Pleural Effusion by Cancer Type and Stage at Presentation - An Analysis of the Surveillance, Epidemiology and End Results (SEER) Medicare Database
    Merlo, Aurelie
    Strassle, Paula
    Gaber, Charles
    Mody, Gita N.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2020, 231 (04) : S295 - S295
  • [2] Non-Metastatic Inflammatory Breast Cancer: A Surveillance, Epidemiology and End Results (SEER) Analysis
    Shamp, S.
    Biswas, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E573 - E573
  • [3] INFLAMMATORY BREAST-CANCER - THE EXPERIENCE OF THE SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM
    LEVINE, PH
    STEINHORN, SC
    RIES, LG
    ARON, JL
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1985, 74 (02): : 291 - 297
  • [4] Economic Burden of Melanoma in the Elderly Population Population-Based Analysis of the Surveillance, Epidemiology, and End Results (SEER)-Medicare Data
    Seidler, Anne M.
    Pennie, Michelle L.
    Veledar, Emir
    Culler, Steven D.
    Chen, Suephy C.
    ARCHIVES OF DERMATOLOGY, 2010, 146 (03) : 249 - 256
  • [5] Surveillance, Epidemiology, and End Results (SEER) and SEER-Medicare Databases: Use in Clinical Research for Improving Colorectal Cancer Outcomes
    Daly, Meghan C.
    Paquette, Ian M.
    CLINICS IN COLON AND RECTAL SURGERY, 2019, 32 (01) : 61 - 68
  • [6] BRACHYTHERAPY IN GLIOBLASTOMA: A SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) ANALYSIS
    Alattar, Ali
    Bartek, Jiri
    Dhawan, Sanjay
    Ma, Jun
    Chen, Clark
    NEURO-ONCOLOGY, 2018, 20 : 139 - 139
  • [7] Pulmonary Carcinosarcoma: A Surveillance, Epidemiology, and End Results (SEER) Analysis
    Ersek, Jennifer L.
    Symanowski, James T.
    Han, Yimei
    Howard, Alexander
    Dumas, Kathryn
    Ahrens, William
    Kim, Elyssa
    Kim, Edward S.
    CLINICAL LUNG CANCER, 2020, 21 (02) : 160 - 170
  • [8] Oligodendroglioma resection: a Surveillance, Epidemiology, and End Results (SEER) analysis
    Alattar, Ali A.
    Brandel, Michael G.
    Hirshman, Brian R.
    Dong, Xuezhi
    Carroll, Kate T.
    Ali, Mir Amaan
    Carter, Bob S.
    Chen, Clark C.
    JOURNAL OF NEUROSURGERY, 2018, 128 (04) : 1076 - 1083
  • [9] Morbidity of local therapy for locally advanced metastatic breast cancer: an analysis of the Surveillance, Epidemiology, and End Results (SEER)–Medicare Registry
    Mark Fairweather
    Wei Jiang
    Nancy L. Keating
    Rachel A. Freedman
    Tari A. King
    Faina Nakhlis
    Breast Cancer Research and Treatment, 2018, 169 : 287 - 293
  • [10] Morbidity of local therapy for locally advanced metastatic breast cancer: an analysis of the Surveillance, Epidemiology, and End Results (SEER)-Medicare Registry
    Fairweather, Mark
    Jiang, Wei
    Keating, Nancy L.
    Freedman, Rachel A.
    King, Tari A.
    Nakhlis, Faina
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 169 (02) : 287 - 293